• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切除术后氟尿嘧啶的眼部毒性

Ocular toxicity of fluorouracil after vitrectomy.

作者信息

Stern W H, Guerin C J, Erickson P A, Lewis G P, Anderson D H, Fisher S K

出版信息

Am J Ophthalmol. 1983 Jul;96(1):43-51. doi: 10.1016/0002-9394(83)90453-1.

DOI:10.1016/0002-9394(83)90453-1
PMID:6869479
Abstract

The retinal and corneal toxicity of fluorouracil in the rabbit eye after lensectomy and vitrectomy depended on both the dosage and the frequency of intraocular injection and was reversible at certain dosages. All eyes in Group 1 (1.25 mg of fluorouracil every 12 hours for four days and then every 24 hours for three days) had opaque corneas by three days; these did not clear for four weeks. Histologic studies showed loss of photoreceptor outer segments and loss of ribosomes in all the retinal cells examined. The electroretinographic b-wave decreased to 0% of the baseline value (no b-wave), and did not recover after three weeks. In Group 2 eyes (1.25 mg of fluorouracil every 24 hours for seven days), corneal opacification increased to a maximum after two weeks and gradually decreased by four weeks. The electroretinographic b-wave diminished to 9.6% of the baseline value at two weeks but later recovered to 62.5% of the baseline value at three weeks. Histologic studies showed loss of photoreceptor outer segments and ribosomes at nine days; both returned to near normal after five weeks. Clinical, electrophysiologic, and histologic studies showed no toxicity in Group 3 eyes (0.5 mg of fluorouracil every 24 hours for seven days). This dosage of fluorouracil exerts a significant antiproliferative effect on injected retinal pigment epithelial cells and is well tolerated by the rabbit eye.

摘要

晶状体切除和玻璃体切除术后,氟尿嘧啶对兔眼视网膜和角膜的毒性取决于眼内注射的剂量和频率,且在一定剂量下是可逆的。第1组所有眼睛(每12小时注射1.25mg氟尿嘧啶,共4天,然后每24小时注射1.25mg氟尿嘧啶,共3天)在3天时角膜均出现混浊,4周后仍未消退。组织学研究显示,在所检查的所有视网膜细胞中,光感受器外节丢失,核糖体减少。视网膜电图b波降至基线值的0%(无b波),3周后仍未恢复。第2组眼睛(每24小时注射1.25mg氟尿嘧啶,共7天),角膜混浊在2周时增至最大,4周时逐渐减轻。视网膜电图b波在2周时降至基线值的9.6%,但在3周时恢复至基线值的62.5%。组织学研究显示,9天时光感受器外节和核糖体减少,5周后两者均恢复至接近正常水平。临床、电生理和组织学研究显示,第3组眼睛(每24小时注射0.5mg氟尿嘧啶,共7天)无毒性。该剂量的氟尿嘧啶对注射的视网膜色素上皮细胞具有显著的抗增殖作用,且兔眼耐受性良好。

相似文献

1
Ocular toxicity of fluorouracil after vitrectomy.玻璃体切除术后氟尿嘧啶的眼部毒性
Am J Ophthalmol. 1983 Jul;96(1):43-51. doi: 10.1016/0002-9394(83)90453-1.
2
Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.
Am J Ophthalmol. 1983 Jul;96(1):33-42. doi: 10.1016/0002-9394(83)90452-x.
3
Aqueous concentrations of fluorouracil after intravitreal injection. Normal, vitrectomized, and silicone-filled eyes.
Arch Ophthalmol. 1986 Mar;104(3):431-4. doi: 10.1001/archopht.1986.01050150133044.
4
Effect of Ca(2+)-free and Mg(2+)-free BSS Plus solution on the retinal pigment epithelium and retina in rabbits.无钙无镁BSS Plus溶液对兔视网膜色素上皮和视网膜的影响。
Am J Ophthalmol. 2001 Apr;131(4):481-8. doi: 10.1016/s0002-9394(00)00899-0.
5
Intraocular safety of ciprofloxacin.
Arch Ophthalmol. 1991 Dec;109(12):1737-43. doi: 10.1001/archopht.1991.01080120121040.
6
Retinal toxicity of intravitreal 5-fluorouracil in silicone-filled rabbit eyes.玻璃体腔内注射5-氟尿嘧啶对硅油填充兔眼的视网膜毒性
J Coll Physicians Surg Pak. 2006 May;16(5):351-4.
7
Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes.
Arch Ophthalmol. 1991 May;109(5):718-22. doi: 10.1001/archopht.1991.01080050134044.
8
The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant.多功能植入物控释后5-氟尿嘧啶对眼组织的体内外作用
Invest Ophthalmol Vis Sci. 2009 May;50(5):2216-23. doi: 10.1167/iovs.08-3016. Epub 2009 Jan 10.
9
Intravitreal toxicity of cotrimoxazole.
Ophthalmic Surg. 1988 Jan;19(1):44-6.
10
Topical fluorouracil. II. Postoperative administration in an animal model of glaucoma filtering surgery.
Arch Ophthalmol. 1986 Jan;104(1):132-6. doi: 10.1001/archopht.1986.01050130146041.

引用本文的文献

1
Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis.5-氟尿嘧啶联合低分子量肝素预防视网膜脱离患者术后增殖性玻璃体视网膜病变的Meta分析
Front Med (Lausanne). 2021 Nov 30;8:790460. doi: 10.3389/fmed.2021.790460. eCollection 2021.
2
A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation.一种用于十六烷氧基丙基9-[2-(膦酰甲氧基)乙基]鸟嘌呤(HDP-PMEG)在眼部异常增殖上持续递送的新型脂质前药策略。
Drug Deliv. 2017 Nov;24(1):1703-1712. doi: 10.1080/10717544.2017.1399303.
3
The impact of octreotide in experimental proliferative vitreoretinopathy.
奥曲肽对实验性增生性玻璃体视网膜病变的影响。
Indian J Ophthalmol. 2013 Mar;61(3):109-14. doi: 10.4103/0301-4738.109380.
4
Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo.体外和体内评估折叠式囊袋玻璃体中的 5-氟尿嘧啶释放。
Graefes Arch Clin Exp Ophthalmol. 2012 May;250(5):751-9. doi: 10.1007/s00417-011-1862-y. Epub 2011 Nov 27.
5
Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.视觉系统的影响可能是癌症化疗引起的“化疗雾”导致认知缺陷的原因之一。
J Clin Pharm Ther. 2010 Jun;35(3):249-55. doi: 10.1111/j.1365-2710.2009.01086.x.
6
Intravitreal crystalline drug delivery for intraocular proliferation diseases.眼内晶体药物输送治疗眼内增殖性疾病。
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):474-81. doi: 10.1167/iovs.09-3672. Epub 2009 Aug 20.
7
Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU.通过眼内持续递送5-氟尿嘧啶抑制实验性增殖性玻璃体视网膜病变
Int Ophthalmol. 1995;19(1):43-9. doi: 10.1007/BF00156419.
8
Growth inhibition of human Tenon's capsule fibroblasts and rabbit dermal fibroblasts with non-carcinogenic N-alkylated anthracyclines.非致癌性N-烷基化蒽环类药物对人眼球筋膜囊成纤维细胞和兔皮肤成纤维细胞的生长抑制作用
Graefes Arch Clin Exp Ophthalmol. 1994 Jun;232(6):347-54. doi: 10.1007/BF00175986.
9
Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR.
Int Ophthalmol. 1994;18(2):53-60. doi: 10.1007/BF00919240.
10
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.增殖性玻璃体视网膜病变:病理生物学、手术治疗及辅助治疗
Br J Ophthalmol. 1995 Oct;79(10):953-60. doi: 10.1136/bjo.79.10.953.